Shelf life (days): 1460.0
Formulation: A crystalline solid
Formal Name: 2-(4-hydroxyphenyl)ethyl, 6-[(2S,3Z,4S)-3-ethylidene-2-(ß-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2H-pyran-4-acetate], ß-D-glucopyranoside
Purity: ≥95%
Formula Markup: C31H42O17
Formula Weight: 686.65498
CAS Number: 449733-84-0
Notes: Specneuzhenide is an iridoid glycoside originally isolated from L. lucidum with diverse biological activities.{45121,45122,45123,45124} It reduces neurotoxicity induced by 6-OHDA (Item No. 25330) in SH-SY5Y cells by 49.2% when used at a concentration of 10 μM.{45121} Specneuzhenide (25, 50, and 100 μM) reduces high glucose-induced levels of cleaved caspase-3 protein and apoptosis in mouse glomerular mesangial cells.{45122} It increases cell viability and alkaline phosphatase activity in osteoblastic UMR-106 cells.{45123} Specneuzhenide inhibits hypoxia-induced VEGFA secretion, VEGFA and prolyl hydroxylase 2 (PHD-2) mRNA expression, and protein levels of VEGFA, HIF-1α, and PHD-2 in human acute retinal pigment epithelial-19 (ARPE-19) cells.{45124} In vivo, specneuzhenide (5 and 10 mg/kg) prevents retinal neovascularization in a rat model of oxygen-induced retinopathy.
English
Deutsch
